A Jak2-selective inhibitor potently reverses the immune suppression by modulating the tumor microenvironment for cancer immunotherapy
Author:
Publisher
Elsevier BV
Subject
Pharmacology,Biochemistry
Reference45 articles.
1. The future of immune checkpoint therapy;Sharma;Science,2015
2. Clinical use of dendritic cells for cancer therapy;Anguille;Lancet Oncol.,2014
3. Big opportunities for small molecules in immuno-oncology;Adams;Nat. Rev. Drug Discov.,2015
4. Molecular mechanisms of acquired resistance to tyrosine kinase targeted therapy;Sierra;Mol. Cancer,2010
5. Natural innate and adaptive immunity to cancer;Vesely;Ann. Rev. Immunol.,2011
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Stability studies of β-Amino- and β-Hydroxy difluoromethyl ketones in rat serum and rat liver microsomes;Bioorganic & Medicinal Chemistry Letters;2024-09
2. BP1003 Decreases STAT3 Expression and Its Pro-Tumorigenic Functions in Solid Tumors and the Tumor Microenvironment;Biomedicines;2024-08-20
3. Upregulation of MELK promotes chemoresistance and induces macrophage M2 polarization via CSF-1/JAK2/STAT3 pathway in gastric cancer;Cancer Cell International;2024-08-12
4. Knockdown of trem2 promotes proinflammatory microglia and inhibits glioma progression via the JAK2/STAT3 and NF-κB pathways;Cell Communication and Signaling;2024-05-15
5. Synthesis of α,α-Difluoro-β-amino Ketones from N-Boc-α-Amidosulfones and Pentafluoro-gem-diols;The Journal of Organic Chemistry;2024-04-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3